Kazakhstan: A folate-deficient area?

European Journal of Clinical Nutrition

Volumn 60, Issue 9, 2006, Pages 1141-1143

  Akilzhanova, A ^a   Takamura, N ^b   Zhaojia, Y ^b   Aoyagi, K ^b   Karazhanova, L ^a   Yamashita, S ^b,c  

^a SEMEY MEDICAL UNIVERSITY   (Kazakhstan)

^b NAGASAKI UNIVERSITY   (Japan)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; HOMOCYSTEINE;

ADULT; AGE DISTRIBUTION; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; EATING HABIT; FEMALE; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; HUMAN; HYPERHOMOCYSTEINEMIA; JAPAN; KAZAKHSTAN; LIFESTYLE; MALE; MEAT; OBSERVATIONAL STUDY; POPULATION RESEARCH; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; VEGETABLE;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; JAPAN; KAZAKHSTAN; MALE; MIDDLE AGED; NUTRITION ASSESSMENT; NUTRITIONAL STATUS; PREVALENCE; VEGETABLES;

EID: 33748423845     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1602428     Document Type: Article

References (15)

1. Antony AC, Hansen DK (2000). Hypothesis: Folate-responsive neural tube defects and neurochristopathies. Teratology 62, 40-42.
2. Bolander-Gouaille C (2000). Focus an Homocysteine and the Vitamins Involved in its Metabolism. Springer: Paris, pp 1-217.
3. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG (1995). A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274, 1049-1057.
4. Bronstrup A, Hages M, Prinz-Langenohl R, Pietrzik K (1998). Effects of folic acid and combinations of folic acid and vitamin B-12 on plasma homocysteine concentrations in healthy, young women. Am J Clin Nutr 68, 104-1110.
5. Brouwer IA, van Dusseldorp M, West CE, Meyboom S, Thomas CM, Duran M et al. (1999). Low-dose folic acid supplementation decreases plasma homocysteine concentrations: A randomized trial. Am J Clin Nutr 69, 99-104.
6. de Bree A, Verschuren WMM, Blom HJ, Kromhout D (2001). Lifestyle factors and plasma homocysteine concentrations in a general population sample. Am J Epidemiol 154, 150-154.
7. Fallest-Strobl PC, Koch DD, Stein JH, McBride PE (1997). Homocysteine: A new risk factor for atherosclerosis. Am Fam Physician 56, 1607-1612.
8. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM et al. (1997). Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 277, 1775-1781.
9. Hamada A, Zakupbekova M, Sagandikova S, Espenbetova M, Ohashi T, Takamura N (2003). Iodine prophylaxis around the Semipalatinsk Nuclear Testing Site, Republic of Kazakstan. Public Health Nutr 6, 785-789.
10. James SJ, Pogribna M. Pogribny IP, Melnyk S, Hine RJ, Gibson JB et al. (1999). Abnormal folate metabolism and mutation in the methylentetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. Am J Clin Nutr 70, 495-501.
11. Lucock M (2000). Folic acid: Nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab 71, 121-138.
12. Lussier-Cocan S, Xhignesse M, Piolot A, Selhub J, Davignon J (1996). Plasma level homocysteine in healthy subjects: Sex-specific relation with biological traits. Am J Clin Nutr 64, 587-593.
13. van Oort ITV, Melse-Boonstra A, Brouwer IA, Clarke R, West CE, Katan MB et al. (2003). Folic acid and reduction of plasma homocysteine concentrations in older adults: A dose-response study. Am J Clin Nutr 77, 1318-1323.
14. Vermeulen EG, Stehouwer CD, Twisk JW, van den Berg M, de Jong SC, Mackaay AJ et al. (2000). Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: A randomised, placebo-controlled trial. Lancet 355, 517-522.
15. Yamamoto M, Tsukatani T, Katayama Y (1996). Residual radioactivity in the soil of the Semipalatinsk nuclear test site in the former USSR. Health Phys 71, 142-148.